Fresenius SE & Co. KGaA (VIE:FRE)

Austria flag Austria · Delayed Price · Currency is EUR
49.47
+0.49 (1.00%)
At close: Feb 4, 2026
32.98%
Market Cap27.82B +37.6%
Revenue (ttm)22.45B +4.5%
Net Income1.14B
EPS2.03
Shares Outn/a
PE Ratio24.34
Forward PE13.24
Dividend1.00 (2.12%)
Ex-Dividend DateMay 26, 2025
Volume2
Average Volume208
Open48.97
Previous Close48.98
Day's Range48.97 - 49.47
52-Week Range35.29 - 51.70
Betan/a
RSI54.78
Earnings DateFeb 25, 2026

About Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through Fresenius Kabi and Fresenius Helios segment. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The company was formerly know... [Read more]

Industry Miscellaneous Health And Allied Services, Not Elsewhere Classified
Founded 1912
Employees 177,356
Stock Exchange Vienna Stock Exchange
Ticker Symbol FRE
Full Company Profile

Financial Performance

Financial Statements